Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Avista Pharma

Avista Pharma
2015 FOUNDED
M&A STATUS
301-400 EMPLOYEES
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
3 INVESTMENTS
Description

Provider of contract development, manufacturing, and testing services of newly created medicinal drugs. The company offers a broad suite of scientifically differentiated services ranging from early-stage discovery, API and Drug Product development and cGMP manufacturing to stand-alone analytical and microbiology testing support of medicines.

Formerly Known As
Microtest Labs
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Parent Company
Primary Office
  • Durham, NC
  • United States

Avista Pharma Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Avista Pharma‘s full profile, request access.

Request full access to PitchBook

Avista Pharma Competitors (28)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Dalton Pharma Services Corporation Toronto, Canada 00 0000000000
00000000 Private Equity-Backed Guildford, United Kingdom 000 0000000 0000
000000 Formerly VC-backed San Diego, CA 00 000000&0
000000 Angel-Backed San Diego, CA 00 00.00 0000000000 00.00
0000000 000000 Corporation Tokyo, Japan 00000 000000&0
To view this company’s complete list of competitors, request access »

Avista Pharma Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 0000 0000000 23-Jan-2018 000000000000000000 Biotechnology 0000000 00000
000000000 000 0000 07-Aug-2015 000000000000000000 Laboratory Services (Healthcare)
Scynexis (Contract Services Business) 23-Jul-2015 Merger/Acquisition Pharmaceuticals 0000000 00000
To view this company’s complete investment and acquisition history, request access »

Avista Pharma Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000000 000 0000 07-Aug-2015 000000000000000000 Completed
  • 000000 000000
To view this company’s complete exits history, request access »

Avista Pharma Subsidiaries (1)

Company Name Industry Location Founded
00000 0000 0000000 Biotechnology Penicuik, United Kingdom 0000
To view this company’s complete subsidiary history, request access »

Avista Pharma Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Avista Pharma‘s full profile, request access.

Request full access to PitchBook

Avista Pharma Executive Team (6)

Name Title Board
Seat
Contact
Info
Patrick Walsh Chief Executive Officer & Member of the Board of Directors
Eric Evans Chief Financial Officer
Ken Domagalski Chief Operating Officer of CMC Operations
Cathy Butler Chief Information Officer
Rob Goshert Vice President, Business Operations

1 Former Executive

You’re viewing 5 of 6 executives. Get the full list »

Avista Pharma Board Members (3)

Name Representing Role Since Contact
Info
00000 000000 Ampersand Capital Partners Board Member 000 0000
0000 000000 00.0 Avista Pharma Board Member 000 0000
000000 000000000 Ampersand Capital Partners Board Member 000 0000